The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Long-chain carboxychromanols, metabolites of vitamin E, are potent inhibitors of cyclooxygenases
Open accessAbstract
Cyclooxygenase (COX-1/COX-2)-catalyzed eicosanoid formation plays a key role in inflammation-associated diseases. Natural forms of vitamin E are recently shown to be metabolized to long-chain carboxychromanols and their sulfated counterparts. Here we find that vitamin E forms differentially inhibit COX-2-catalyzed prostaglandin E 2 in IL-1β-stimulated A549 cells without affecting COX-2 expression, showing the relative potency of γ-tocotrienol ≈ δ-tocopherol > γ-tocopherol ≫ α- or β-tocopherol. The cellular inhibition is partially diminished by sesamin, which blocks the metabolism of vitamin E, suggesting that their metabolites may be inhibitory. Consistently, conditioned media enriched with long-chain carboxychromanols, but not their sulfated counterparts or vitamin E, reduce COX-2 activity in COX-preinduced cells with 5 μM arachidonic acid as substrate. Under this condition, 9′- or 13′-carboxychromanol, the vitamin E metabolites that contain a chromanol linked with a 9- or 13-carbon-length carboxylated side chain, inhibits COX-2 with an IC 50 of 6 or 4 μM, respectively. But 13′-carboxychromanol inhibits purified COX-1 and COX-2 much more potently than shorter side-chain analogs or vitamin E forms by competitively inhibiting their cyclooxygenase activity with K i of 3.9 and 10.7 μM, respectively, without affecting the peroxidase activity. Computer simulation consistently indicates that 13′-carboxychromanol binds more strongly than 9′-carboxychromanol to the substrate-binding site of COX-1. Therefore, long-chain carboxychromanols, including 13′-carboxychromanol, are novel cyclooxygenase inhibitors, may serve as anti-inflammation and anticancer agents, and may contribute to the beneficial effects of certain forms of vitamin E.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kollman, P. A., Massova, I., Reyes, C., Kuhn, B., Huo, S., Chong, L., Lee, M., Lee, T., Duan, Y., Wang, W., et al. (2000) · Accounts of Chemical Research · doi:10.1021/ar000033j · Cited by 4,978
γ-Tocopherol, the major form of vitamin E in the US diet, deserves more attention
Jiang, Q., Christen, S., Shigenaga, M. K., & Ames, B. N. (2001) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/74.6.714 · Cited by 776
Self-citationBoutaud, O., Aronoff, D. M., Richardson, J. H., Marnett, L. J., & Oates, J. A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.102588199 · Cited by 209
Cited by
Jiang, Q. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.03.035 · Cited by 899
Self-citationAggarwal, B. B., Sundaram, C., Prasad, S., & Kannappan, R. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.07.043 · Cited by 566
Vitamin E: Emerging aspects and new directions
Galli, F., Azzi, A., Birringer, M., Cook-Mills, J. M., Eggersdorfer, M., Frank, J., Cruciani, G., Lorkowski, S., & Özer, N. K. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.09.017 · Cited by 448
Vitamin E therapy beyond cancer: Tocopherol versus tocotrienol
Peh, H. Y., Tan, W. S. D., Liao, W., & Wong, W. S. F. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.12.003 · Cited by 351
Pharmacological potential of tocotrienols: a review
Ahsan, H., Ahad, A., Iqbal, J., & Siddiqui, W. A. (2014) · Nutrition & Metabolism · doi:10.1186/1743-7075-11-52 · Cited by 328
Metadata
- Authors
- Jiang, Q., Yin, X., Lill, M. A., Danielson, M. L., Freiser, H., & Huang, J.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2008-12-23
- Volume
- 105
- Issue
- 51
- Pages
- 20464-20469
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2009655951
- Cited by
- 185
- References
- 3
- FWCI
- 6.15
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Long-chain carboxychromanols, metabolites of vitamin E, are potent inhibitors of cyclooxygenases. https://app.cochat.ai/papers/10.1073/pnas.0810962106
- The paper
- Jiang, Q., Yin, X., Lill, M. A., Danielson, M. L., Freiser, H., & Huang, J. (2008). Long-chain carboxychromanols, metabolites of vitamin E, are potent inhibitors of cyclooxygenases. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.0810962106
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.